33 Stocks Moving In Monday's Mid-Day Session

Gainers

• JanOne Inc. JAN shares climbed 97.7% to $5.04 after the company announced it purchased a worldwide exclusive license for TV1001SR, a treatment for peripheral arterial disease. No terms were disclosed.
• The Peck Company Holdings, Inc. PECK gained 68.1% to $3.85.
• Sorrento Therapeutics, Inc. SRNE shares rose 46.9% to $2.35 after the company announced it has recieved and rejected an unsolicited, all cash proposal from two biopharmaceutical companies between $3-$5 per share in cash.
• The Medicines Company MDCO shares rose 22.4% to $83.87 after the company announced it will be acquired by Novartis AG for $85 per share.
• Aquestive Therapeutics, Inc. AQST shares rose 21.7% to $7.83 after the company received the FDA approval for EXSERVAN for the treatment of amyotrphic lateral sclerosis.
• Arrowhead Pharmaceuticals Inc ARWR gained 16.3% to $57.22 after Baird upgraded the company's stock from Neutral to Outperform and raised the price target from $39 to $70.
• BioCryst Pharmaceuticals, Inc. BCRX climbed 13.1% to $2.545.
• InMode Ltd. INMD gained 12.7% to $46.81. This could potentially be a rebound after the stock the dropped approximately 23% over the past 4 trading sessions
• IEC Electronics Corp. IEC shares rose 10.8% to $8.64.
• Five Prime Therapeutics, Inc. FPRX climbed 10.5% to $3.91.
• Intercept Pharmaceuticals, Inc. ICPT rose 10.5% to $98.22. Intercept Pharma disclosed that the FDA has accepted New Drug Application for obeticholic acid for the treatment of fibrosis due to nonalcoholic steatohepatitis and granted priority review.
• IVERIC bio, Inc. ISEE climbed 10.2% to $3.6350
• Neoleukin Therapeutics, Inc. NLTX gained 9.5% to $3.7994.
• Zynex, Inc. ZYXI gained 9.5% to $9.80.
• Kamada Ltd. KMDA rose 9% to $7.51.
• Chico's FAS, Inc. CHS climbed 8.7% to $4.075 in anticipation of the company's Q3 earnings scheduled for tomorrow before the open.
• ArQule, Inc. ARQL gained 8.2% to $8.86. The company earlier announced it will present clinical data from its Phase 1 study of ARQ 531 at the ASH Annual Meeting on December 9th.
• U.S. Silica Holdings, Inc. SLCA gained 8.1% to $4.92.
• Zscaler, Inc. ZS shares rose 6.1% to $49.15 after Bank of America upgraded the company's stock from Neutral to Buy.
• Tiffany & Co. TIF rose 6% to $133.06 after LVMH confirmed an agreement to buy the company in a $16.2 billion bid.

Check out these big penny stock gainers and losers

Losers

• CymaBay Therapeutics Inc CBAY shares tumbled 76.2% to $1.32 after the company reported a halt in the clinical development of its Seladelpar.
• La Jolla Pharmaceutical Company LJPC fell 55.2% to $2.50 after the company reported that President and CEO George Tidmarsh has left the company. La Jolla Pharmaceutical disclosed that it will reassess continued development of LJPC-401 based on recent clinical results.
• Adamis Pharmaceuticals Corp ADMP shares dropped 48.8% to $0.6449 after the company reported it received a complete response letter from the FDA for its ZIMHI. The FDA stated it cannot approve the ZIMHI in its present form and provided suggested needed for resubmission.
• BlueLinx Holdings Inc. BXC fell 28.2% to $8.93.
• AMERI Holdings, Inc. AMRH shares dropped 19.6% to $2.19.
• Kirkland Lake Gold Ltd KL shares dipped 16% to $40.02 after the company, along with Detour Gold, announced Kirkland Lake Gold will acquire all of the issued and outstanding securities of Detour Gold.
• Kazia Therapeutics Limited KZIA fell 16.7% to $6.17 after reporting interim data from ongoing Phase 2 study of GDC-0084 in glioblastoma.
• Vislink Technologies Inc VISL tumbled 15.3% to $0.25. Vislink Technologies priced its common stock and warrant offering for $4 million.
• Akerna Corp. KERN dipped 12.9% to $6.31.
• CANAAN INC. CAN fell 12.4% to $7.87. The stock has been volatile since Thursday's IPO, in which it opened at $12.60, above the IPO price of $9.
• Surface Oncology, Inc. SURF shares declined 11.7% to $2.0573 after the company reported a $25 million debt financing from K2 HealthVentures.
• GTT Communications, Inc. GTT fell 8.1% to $5.12.
• Silvergate Capital Corporation SI shares dropped 7.7% to $14.46.